Cracking Cancer 2.0 - Panel Discussion

Startup Exchange Video | Duration: 47:30
December 7, 2017
Cracking Cancer 2.0 - Panel Discussion
Please login to view this video.
Locked Interactive transcript
  • Video details

    Panel Discussion: What are the latest advances in cancer innovation?

    Moderated by Trond Undheim, PhD, Program Director, MIT Startup Exchange

     

    · The here and now: Where are we today? What new tech tools and approaches are available? 

    · What are the most successful cancer startups from MIT doing at the moment and why?

    · What’s on the near horizon? What new applications are opening up? What are the investment opportunities? What is the smart money focused on? What are corporate priorities in seeking novel cancer treatments/drugs? What does the new cancer innovation ecosystem look like (infrastructure, interoperability, technology, use cases, stakeholders, success stories)?

    · The future: What advances will we see over the next few years? What's in it for patients? What are you personally the most excited about?

     

    Panelists

    • Paula T. Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT, Member of the Koch Institute of Integrative Cancer Research, and Cofounder of Svaya Nanotechnologies and LayerBio
    • Laura Indolfi, PhD, CEO of PanTher Therapeutics, TED Fellow
    • Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas
Cracking Cancer 2.0 - Panel Discussion
Please login to view this video.
Locked Interactive transcript
  • Video details

    Panel Discussion: What are the latest advances in cancer innovation?

    Moderated by Trond Undheim, PhD, Program Director, MIT Startup Exchange

     

    · The here and now: Where are we today? What new tech tools and approaches are available? 

    · What are the most successful cancer startups from MIT doing at the moment and why?

    · What’s on the near horizon? What new applications are opening up? What are the investment opportunities? What is the smart money focused on? What are corporate priorities in seeking novel cancer treatments/drugs? What does the new cancer innovation ecosystem look like (infrastructure, interoperability, technology, use cases, stakeholders, success stories)?

    · The future: What advances will we see over the next few years? What's in it for patients? What are you personally the most excited about?

     

    Panelists

    • Paula T. Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT, Member of the Koch Institute of Integrative Cancer Research, and Cofounder of Svaya Nanotechnologies and LayerBio
    • Laura Indolfi, PhD, CEO of PanTher Therapeutics, TED Fellow
    • Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas